论文部分内容阅读
目的:探讨血清IL-6、血清CA153检测在乳腺癌诊治中的临床价值。方法:回顾性分析我院收治的38例乳腺癌患者及65例乳腺良性疾病患者血清IL-6、血清CA153检测结果,并与40例正常健康人结果作对比。结果:乳腺癌组血清IL-6、血清CA153水平及阳性率均显著高于乳腺良性疾病组及健康对照组,差异有统计学意义(P<0.05)。结论:血清IL-6、血清CA153水平与乳腺癌患者的病情和预后密切相关,检测血清IL-6、血清CA153水平对乳腺癌诊治具有一定的临床价值。
Objective: To investigate the clinical value of serum IL-6 and serum CA153 in the diagnosis and treatment of breast cancer. Methods: The serum levels of IL-6 and serum CA153 in 38 patients with breast cancer and 65 patients with benign breast diseases admitted to our hospital were analyzed retrospectively. The results were compared with those of 40 normal healthy subjects. Results: The levels of serum IL-6, serum CA153 and the positive rate in breast cancer patients were significantly higher than those in benign breast disease patients and healthy controls (P <0.05). Conclusion: Serum IL-6 and serum CA153 levels are closely related to the disease status and prognosis of patients with breast cancer. Detecting serum IL-6 and serum CA153 levels have certain clinical value in the diagnosis and treatment of breast cancer.